Graham Capital Management »

Bridgebio Pharma shares owned by Graham Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $58M 56M 1.03
2024-06-30 $74M 73M 1.01
2024-03-31 $79M 73M 1.08
2023-12-31 $89M 73M 1.21
2023-09-30 $54M 56M 0.96

More positions owned by Graham Capital Management

Microstrategy Cl A New Put Option (MSTR)
Ishares Tr Russell 2000 Etf (IWM)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Microstrategy Note 2/1 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Vaneck Etf Trust Junior Gold Mine Call Option (GDXJ)
Tilray Brands Note 5.200% 6/1 (Principal)
Novavax Note 5.000%12/1 (Principal)
Bloom Energy Corp Note 2.500% 8/1 (Principal)
Penn Entertainment Note 2.750% 5/1 (Principal)
Coinbase Global Note 0.500% 6/0 (Principal)

View all positions for Graham Capital Management

Top funds holding Bridgebio Pharma

Braidwell
Graham Capital Management
Weiss Asset Management LP[1
Advent Capital Management
Point72 Asset Management
Aristeia Capital
Wolverine Asset Management
683 Capital Management
Lazard Asset Management
Wells Fargo & Company
State Street Corporation
Calamos Advisors
Jump Financial
New York State Common Retirement Fund
SSI Investment Management

View all funds holding Bridgebio Pharma